Most primary central nervous system diffuse large B-cell lymphomas occurring in immunocompetent individuals belong to the nongerminal center subtype: a retrospective analysis of 31 cases
- PMID: 19935644
- DOI: 10.1038/modpathol.2009.164
Most primary central nervous system diffuse large B-cell lymphomas occurring in immunocompetent individuals belong to the nongerminal center subtype: a retrospective analysis of 31 cases
Abstract
Primary central nervous system lymphomas are rare neoplasms characterized by a dismal prognosis relative to other extranodal lymphomas. Approximately 98% of primary central nervous system lymphomas are of B-cell origin, and most belong to the diffuse large B-cell type. Recently, diffuse large B-cell lymphomas have been subcategorized into germinal center and nongerminal center types based on gene expression profiles and immunohistochemical expression of CD10, Bcl-6, and MUM1. Studies have shown that the overall survival rate of the germinal center group is better than that of the nongerminal center lymphomas. In this study, 31 cases of primary central nervous system lymphomas of the diffuse large B-cell type were retrieved, reviewed, and immunostained for CD10, Bcl-6, MUM1, and Ki-67. Subclassification was carried out as described earlier, where CD10 and/or Bcl-6 positivity and negativity for MUM1 were considered characteristic of germinal center subtype and the opposite expression of nongerminal center subtype. Furthermore, the proliferative activity was semiquantitatively assessed using percent positive cells staining with Ki-67. Of the 31 cases examined, 26 (84%) were found to belong to the nongerminal center type. The Ki-67 index in these 26 cases ranged from 30 to 90% (mean, 69%). Five cases were categorized as the germinal center subtype. They had an Ki-67 index between 70 and 90% (mean, 78%). Interestingly, none of our patients were known to be HIV positive. One patient had a 10-year history of orthotopic liver transplant. We also performed fluorescence in situ hybridization analysis on formalin-fixed material and found that 38% of the cases where tissue was available had abnormalities of MYC/IGH and/or IGH/BCL2. We conclude that most primary central nervous system diffuse large B-cell lymphomas are of the nongerminal center origin. Regardless of the germinal center status, all cases showed a high proliferative rate. A statistically significant difference in the overall survival between the two groups was not seen.
Similar articles
-
Primary breast diffuse large B-cell lymphoma shows a non-germinal center B-cell phenotype.Mod Pathol. 2005 Mar;18(3):398-405. doi: 10.1038/modpathol.3800266. Mod Pathol. 2005. PMID: 15492762
-
Primary testicular diffuse large B-cell lymphoma belongs to the nongerminal center B-cell-like subgroup: A study of 18 cases.Mod Pathol. 2006 Dec;19(12):1521-7. doi: 10.1038/modpathol.3800691. Epub 2006 Sep 22. Mod Pathol. 2006. PMID: 16998463
-
Nodal diffuse large B-cell lymphomas in children and adolescents: immunohistochemical expression patterns and c-MYC translocation in relation to clinical outcome.Am J Surg Pathol. 2009 Dec;33(12):1815-22. doi: 10.1097/PAS.0b013e3181bb9a18. Am J Surg Pathol. 2009. PMID: 19816150 Free PMC article.
-
Primary bone diffuse large B-cell lymphoma: clinicopathologic study of 21 cases and review of literature.Am J Surg Pathol. 2009 Oct;33(10):1463-9. doi: 10.1097/PAS.0b013e3181b314ce. Am J Surg Pathol. 2009. PMID: 19675454 Review.
-
Primary Intra-Axial Diffuse Large B-Cell Lymphoma in Immunocompetent Patients: Clinical Impact of Molecular Analysis and Histogenetic Evaluation.World Neurosurg. 2020 Feb;134:215-220. doi: 10.1016/j.wneu.2019.09.158. Epub 2019 Oct 9. World Neurosurg. 2020. PMID: 31605845 Review.
Cited by
-
Clinicopathological study of gene rearrangement and microRNA expression of primary central nervous system diffuse large B-cell lymphomas.Int J Clin Exp Pathol. 2013 Sep 15;6(10):2048-55. eCollection 2013. Int J Clin Exp Pathol. 2013. PMID: 24133582 Free PMC article.
-
Primary central nervous system lymphoma in immunocompetent individuals: a single center experience.Int J Clin Exp Pathol. 2013 May 15;6(6):1068-75. Print 2013. Int J Clin Exp Pathol. 2013. PMID: 23696924 Free PMC article.
-
BCL2 expression is associated with a poor prognosis independent of cellular origin in primary central nervous system diffuse large B-cell lymphoma.J Neurooncol. 2018 Oct;140(1):115-121. doi: 10.1007/s11060-018-2940-3. Epub 2018 Jul 2. J Neurooncol. 2018. PMID: 29968039
-
A Set of 17 microRNAs Common for Brain and Cerebrospinal Fluid Differentiates Primary Central Nervous System Lymphoma from Non-Malignant Brain Tumors.Biomolecules. 2021 Sep 21;11(9):1395. doi: 10.3390/biom11091395. Biomolecules. 2021. PMID: 34572608 Free PMC article.
-
Recent advances and challenges in primary central nervous system lymphoma: a narrative review.Transl Cancer Res. 2023 May 31;12(5):1335-1352. doi: 10.21037/tcr-22-2341. Epub 2023 Apr 28. Transl Cancer Res. 2023. PMID: 37304530 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources